Completed PHASE2 INTERVENTIONAL 2-arm NCT02117609

Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes (PRESAGE-T2)

Effet d'Une supplémentation Avec Une Nouvelle préparation hyperprotéinée et Hypercalorique Sur l'évolution Des paramètres Fonctionnels, Nutritionnels et Cognitifs Chez la Personne âgée en Institution

Sponsor: Lactalis

Conditions Malnutrition

Interventions New DELICAL formula Standard DELICAL formula

Updated 5 times since 2017 Last updated: Oct 6, 2015 Started: May 31, 2012 Primary completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02117609, this PHASE2 trial focuses on Malnutrition and remains completed. Sponsored by Lactalis, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lactalis
National Research Agency, France
University Hospital, Toulouse
University of Lille Nord de France

Data source: Lactalis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France